Shreeji Translogistics provides surface transportation and logistics services across India, specializing in full-truck-load, bonded trucking for air cargo, and multimodal rail-road solutions for industrial clients.
The company operates in a highly fragmented industry with low barriers to entry, evidenced by thin net margins of 2.4%. While bonded trucking offers a niche regulatory advantage, the lack of durable pricing power is reflected in the sharp decline in profitability when operating costs like fuel and tolls rise.
Capital has been deployed toward fleet expansion and new business verticals like rake handling, but EPS has declined significantly despite revenue growth. The recent decision to skip the dividend in FY25 to conserve working capital suggests tightening liquidity.
The investment collapsed as the company's aggressive fleet expansion and diversification into rake handling failed to generate incremental returns, leading to a classic growth trap. While revenue grew, the combination of razor-thin margins and rising interest costs on debt-funded assets squeezed the bottom line into a permanent deficit. The sudden auditor resignation and frequent turnover in key administrative roles foreshadowed internal control failures, and the diversion of capital into related-party loans eventually drained the liquidity needed to sustain operations in a cyclical downturn.
RichFakir rates Shreeji Translogistics Ltd's business quality as mediocre — 40/100 on our quality score (profitability, growth, balance-sheet strength and capital allocation). We assess its competitive moat as none.
On our model, Shreeji Translogistics Ltd is trading about 30% below our estimate of fair value; we rate its price cheap. This is an educational estimate from public filings, not a recommendation.
RichFakir's educational verdict on Shreeji Translogistics Ltd is: Not rated. A mediocre business at a cheap price — it does not make our shortlist right now.
RichFakir's educational estimate of Shreeji Translogistics Ltd's fair value is about ₹12 per share, derived from public filings. It's our estimate for research — not a price target or a recommendation to buy or sell.
View the full live analysis →